{"title": "Diabetes' sworn enemy could ultimately be a valuable ally", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/chronic_illness.xml", "value": "Diabetes' sworn enemy could ultimately be a valuable ally"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190306081722.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190306081722.htm", "summary": "A research team unravels an adaptive mechanism involved in controlling insulin action, showing that glucagon plays a crucial part in it and can thus be a protective asset.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/chronic_illness.xml", "value": "A research team unravels an adaptive mechanism involved in controlling insulin action, showing that glucagon plays a crucial part in it and can thus be a protective asset."}, "published": "Wed, 06 Mar 2019 08:17:22 EST", "published_parsed": [2019, 3, 6, 13, 17, 22, 2, 65, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190306081722.htm", "guidislink": false}